These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 34529396)

  • 1. Oligoprogression After Immunotherapy and Targeted Therapy in Metastatic Melanoma.
    Sobrevilla-Moreno N; Rivera-Sánchez D; García-Ortega D; López-Macías D; Garcilazo-Reyes A; Álvarez-Avitia M
    Oncology (Williston Park); 2021 Sep; 35(9):562-566. PubMed ID: 34529396
    [No Abstract]   [Full Text] [Related]  

  • 2. [New treatments for metastatic melanoma: a first hope].
    Robert C; Mateus C
    Rev Prat; 2011 Nov; 61(9 Suppl):S1-2. PubMed ID: 22338196
    [No Abstract]   [Full Text] [Related]  

  • 3. Stability of BRAF V600E mutation in metastatic melanoma: new insights for therapeutic success?
    Sigalotti L; Fratta E; Parisi G; Coral S; Maio M
    Br J Cancer; 2011 Jul; 105(2):327-8. PubMed ID: 21694724
    [No Abstract]   [Full Text] [Related]  

  • 4. The conquest of melanoma by immunotherapy.
    Lejeune FJ
    Melanoma Res; 2015 Oct; 25(5):373-5. PubMed ID: 26173006
    [No Abstract]   [Full Text] [Related]  

  • 5. Active surrender.
    Collisson EA
    Pigment Cell Melanoma Res; 2012 May; 25(3):292-3. PubMed ID: 22629566
    [No Abstract]   [Full Text] [Related]  

  • 6. Combination of Immunotherapy With Targeted Therapy: Theory and Practice in Metastatic Melanoma.
    Yu C; Liu X; Yang J; Zhang M; Jin H; Ma X; Shi H
    Front Immunol; 2019; 10():990. PubMed ID: 31134073
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Systemic therapy for previously untreated advanced BRAF-mutated melanoma: navigating a shifting landscape.
    Levine O; Devji T; Xie F
    Immunotherapy; 2017 Mar; 9(5):375-378. PubMed ID: 28357918
    [No Abstract]   [Full Text] [Related]  

  • 8. Principles of Targeted Therapy for Melanoma.
    Sun J; Carr MJ; Khushalani NI
    Surg Clin North Am; 2020 Feb; 100(1):175-188. PubMed ID: 31753111
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Next-Generation Sequencing to Guide Treatment of Advanced Melanoma.
    Griewank KG; Schilling B
    Am J Clin Dermatol; 2017 Jun; 18(3):303-310. PubMed ID: 28229402
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Immunotherapy for BRAF mutant metastatic melanoma.].
    Rossi E
    Recenti Prog Med; 2020 Dec; 111(12):48e-53e. PubMed ID: 33362182
    [TBL] [Abstract][Full Text] [Related]  

  • 11. SEOM clinical guideline for the management of cutaneous melanoma (2020).
    Majem M; Manzano JL; Marquez-Rodas I; Mujika K; Muñoz-Couselo E; Pérez-Ruiz E; de la Cruz-Merino L; Espinosa E; Gonzalez-Cao M; Berrocal A
    Clin Transl Oncol; 2021 May; 23(5):948-960. PubMed ID: 33651321
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Targeting BRAF for patients with melanoma.
    Arkenau HT; Kefford R; Long GV
    Br J Cancer; 2011 Feb; 104(3):392-8. PubMed ID: 21139585
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Unmet needs in melanoma research.
    Aplin A; Bosenberg M; Soengas M; Kos L; Arnheiter H; Kelsh R
    Pigment Cell Melanoma Res; 2014 Nov; 27(6):1003. PubMed ID: 25346049
    [No Abstract]   [Full Text] [Related]  

  • 14. Frontline Therapy for
    Pavlick AC; Fecher L; Ascierto PA; Sullivan RJ
    Am Soc Clin Oncol Educ Book; 2019 Jan; 39():564-571. PubMed ID: 31099689
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Current status and future directions of molecularly targeted therapies and immunotherapies for melanoma.
    Miller DM; Flaherty KT; Tsao H
    Semin Cutan Med Surg; 2014 Jun; 33(2):60-7. PubMed ID: 25085663
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Diffuse melanosis cutis in the setting of BRAF(V600E) mutant melanoma and treatment with targeted therapies.
    Minocha R; Kefford R; Uribe P; Sebaratnam DF; Fernández-Peñas P
    Australas J Dermatol; 2015 May; 56(2):128-30. PubMed ID: 25159853
    [TBL] [Abstract][Full Text] [Related]  

  • 17. An incidental finding.
    Menon SK
    J Fam Pract; 2013 Nov; 62(11):655-9. PubMed ID: 24288711
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Melanoma treatment's changing landscape.
    Jenks S
    J Natl Cancer Inst; 2014 Jun; 106(6):dju176. PubMed ID: 24907389
    [No Abstract]   [Full Text] [Related]  

  • 19. [Molecular pathology of skin melanoma].
    Tímár J; Ladányi A
    Magy Onkol; 2022 Jun; 66(2):101-108. PubMed ID: 35724386
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The potential of BRAF-targeted therapy combined with immunotherapy in melanoma.
    Naderi-Azad S; Sullivan R
    Expert Rev Anticancer Ther; 2020 Feb; 20(2):131-136. PubMed ID: 32003263
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.